Reducing antibiotic use in Croatia

Comment

Vera Vlahović-Palčevski. Lancet Infect Dis. 2010 Oct.

. 2010 Oct;10(10):670-1.

doi: 10.1016/S1473-3099(10)70212-7.

No abstract available

Comment on

Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries.
Huttner B, Goossens H, Verheij T, Harbarth S; CHAMP consortium. Huttner B, et al. Lancet Infect Dis. 2010 Jan;10(1):17-31. doi: 10.1016/S1473-3099(09)70305-6. Lancet Infect Dis. 2010. PMID: 20129146 Review.

Utilization of antimicrobials in Rijeka (Croatia).
Vlahović-Palcevski V, Francetić I, Palcevski G, Rosovic-Bazijanac V. Vlahović-Palcevski V, et al. Pharmacoepidemiol Drug Saf. 2004 Feb;13(2):105-10. doi: 10.1002/pds.876. Pharmacoepidemiol Drug Saf. 2004. PMID: 14998072
Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.
Mimica Matanovic S, Bergman U, Vukovic D, Wettermark B, Vlahovic-Palcevski V. Mimica Matanovic S, et al. Int J Antimicrob Agents. 2010 Oct;36(4):369-73. doi: 10.1016/j.ijantimicag.2010.05.019. Epub 2010 Aug 5. Int J Antimicrob Agents. 2010. PMID: 20688486
Development of antibiotic resistance and its audit in our country: how to develop an antibiotic policy.
Wattal C. Wattal C. Indian J Med Microbiol. 2012 Oct-Dec;30(4):381-3. doi: 10.4103/0255-0857.103755. Indian J Med Microbiol. 2012. PMID: 23183459 No abstract available.
Antibiotic resistance: the perfect storm.
Gould IM. Gould IM. Int J Antimicrob Agents. 2009 Aug;34 Suppl 3:S2-5. doi: 10.1016/S0924-8579(09)70549-7. Int J Antimicrob Agents. 2009. PMID: 19596110 Review.
Antibiotic policy.
Gyssens IC. Gyssens IC. Int J Antimicrob Agents. 2011 Dec;38 Suppl:11-20. doi: 10.1016/j.ijantimicag.2011.09.002. Epub 2011 Oct 21. Int J Antimicrob Agents. 2011. PMID: 22018989 Review.